An assay based on RD1 selected peptides for the diagnosis of extra-pulmonary and smear negative tuberculosis Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008
Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006
Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to M. tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 363s Year: 2006
The rate of tuberculosis infection in closed contacts of smear positive pulmonary tuberculosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 474s Year: 2002
Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006
Transmission of Mycobacterium tuberculosis to households of tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 197s Year: 2005
A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB Source: Eur Respir J 2005; 26: Suppl. 49, 240s Year: 2005
Utility of MPT64 antigen detection test for diagnosis of HIV coinfected extrapulmonary tuberculosis in Tanzania Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019
Smear negative pulmonary tuberculosis in HIV: Over diagnosed or under investigated Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
Mycobacterium tuberculosis DNA detection in urine samples from pulmonary tuberculosis patients Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Treatment outcomes of smear positive pulmonary tuberculosis cases Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
The latent tuberculosis infection among household contacts of newly diagnosed patients with sputum-positive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 142s Year: 2003
Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012
Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Performance of RD-1 based blood assays in clinical management of smear-negative pulmonary and extra-pulmonary tuberculosis Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 376 Year: 2011
Quantiferon–TB Gold test in cases of active pulmonary tuberculosis initially and during treatment Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007
Peculiarities in implementation of national tuberculosis program in patients with smear negative pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 190s Year: 2004